| Term 
 
        | Norepinephrine (Levophed) |  | Definition 
 
        | •Start at 0.5 - 1.0 mcg/min •Titrate to desired effect (SBP of 90 - 100 mmHg); up to 30 mcg/min
 •Adult dosage commonly 2 - 12 mcg/min
 •Mix 4 ml ampule (1 mg/ml) in 500 ml D5W or 0.9% NSS to make 8 mcg/ml
 |  | 
        |  | 
        
        | Term 
 
        | Phenylephrine (Neo-synephrine) |  | Definition 
 
        | •Titrate 0.1 - 0.18 mg/min until BP stabilizes, then 0.04 - 0.06 mg/min for maintenance infusion. •Dilute 10 mg in 500 ml D5W or 0.9% NSS to make 0.2 mg/ml concentration.
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | •Low dose: 2 - 5 mcg/kg/min •Mid-range dose: 5 - 10 mcg/kg/min
 •High dose: > 10 mcg/kg/min
 •Titrate dosage to desired hemodynamic effect, using data from right heart catheterization as measure of effects.
 •Dilute 400 mg in 250 ml D5W for concentration of 1600 mcg/ml.
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | •Start at 0.5 mcg/kg/min IV and titrate to desired effect •Usual dose is 2 - 20 mcg/kg/min
 •Insertion of Swan-Ganz catheter for continuous pressure monitoring
 •Titrate upward so as not to increase heart rate by greater than 10% (unless for stress echocardiogram).
 •Dilute 1000 mg in 250 ml of D5W or 0.9% NSS for a concentration of 4 mg/ml.
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | •Cardiac arrest: single bolus of 40 units IV; use epinephrine if no response in 10 - 20 minutes •Currently acceptable via endotracheal route; no set dosage as of current ACLS guidelines
 -Vasodilatory Shock: Initially, 0.04 unit/min. DO NOT TITRATE!
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | •Intravenously: •Start at 10 - 20 mcg/min and titrate until desired effect (pain free) is noted or to a maximum of 500 mcg/min.
 •Bolus with 12.5 - 25.0 mcg, then start infusion
 •Best for patients with unstable angina or for continuous treatment for AMI
 •Dilute 40 mg with 250 ml D5W or 0.9% NSS for a concentration of 160 mcg/ml.
 •Transdermal ointment:
 •For chronic therapy, not for acute treatment of chest pain
 •1 - 2 inches of 2% paste applied to the chest wall
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | •Dosage varies with patient’s size, age, and renal function. •Start with 2 - 10 mg slow IV over 3-5 minutes.
 •Titrate in small increments (1 - 3 mg) to desired effect, while maintaining adequate respiratory status.
 |  | 
        |  | 
        
        | Term 
 
        | Sodium nitroprusside (Nipride) |  | Definition 
 
        | •Start infusion at 0.5 mcg/kg/min and titrate every 5 - 10 minutes to desired effect (SBP < 150 mmHg and/or DBP < 60 - 90 mmHg). •Normal range is 0.5 - 8.0 mcg/kg/min.
 •Mix 50 mg with 2 - 3 ml of D5W in the vial, then add 250 ml of D5W for a concentration of 200 mcg/ml.
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | •Hypertension in adults: •: 10 - 50 mg QID
 •Intravenous: 5 - 40 mg slow IV push over 1 - 2 minutes, may repeat every 4 - 6 hours as needed
 •Hypertension in geriatrics: start with 10 mg PO BID or TID and titrate as needed
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | •Loading dose: 0.75 mcg/kg over 2-5 minutes •Infusion at 5 - 10 mcg/kg/min, titrated to desired effect
 •Adjust frequently to achieve optimal effects at lowest possible dose
 •Mix 20 ml ampule of 100 mg (5 mg/ml) with 0.9% NSS for 1 - 3 mg/ml concentration
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | •Initial loading dose: 50 mcg/kg slow IVP over 10 minutes •Continuous infusion: 0.375 - 0.75 mcg/kg/min
 •Titrate dosage to maximum clinical effects (patient improvement, increase in urinary output, improvement in right-heart hemodynamics)
 •Drug is commonly used concomitantly with digitalis and diuretics.
 •In patients with renal impairment, the maximum dose is 1.13 mg/kg/day.
 |  | 
        |  | 
        
        | Term 
 
        | Digitalis (Digoxin, Lanoxin) |  | Definition 
 
        | •Loading dose: 10 - 15 mcg/kg •IV effects in 5 - 30 minutes and peaks in 1.5 - 3.0 hours
 •Maintenance dosing dependent on body size and renal function (monitor creatinine clearance)
 •Normal therapeutic range is 0.5 - 2.0 ng/ml.
 •Also available in oral preparations (0.125, 0.25, and 0.50 mg tablets)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | •Intravenous: 20 - 80 mg IV, usually in increments of 20 mg •Oral: 20 - 40 mg initially, titrated for effect
 |  | 
        |  | 
        
        | Term 
 
        | Dosages for Sodium Heparin (Anticoagulant) |  | Definition 
 
        | •50 u/kg •For acute myocardial infarction (AMI) 5000u loading and 1000 u/hr
 |  | 
        |  | 
        
        | Term 
 
        | Dosages for ReoPro (Abciximab) (Antiplatelet)
 (Glycoprotein (GP) IIb/IIIa inhibitor)
 |  | Definition 
 
        | •.25 mg/kg bolus •Then .125 mcg/kg/min for MI
 •For PCI post, 10 mcg/kg/min for 12 hours
 |  | 
        |  | 
        
        | Term 
 
        | Dosages for Tirofiban HCL (Aggrastat)
 (Antiplatelet)
 |  | Definition 
 
        | •Initial dose of 0.4 mcg/kg/min for 30 minutes •Followed by 0.1 mcg/kg/min for 48 to 108 hours or 12 – 24 hours after coronary intervention
 |  | 
        |  | 
        
        | Term 
 
        | Dosages for Bivalirudin (Angiomax) •Antithrombotic
 |  | Definition 
 
        | •Initially, 1 mg/kg IV bolus just before PCI •Infusion at 2.5 mg/kg/hr for 4 hours
 •Administer another IV infusion at 0.2 mg/kg/hr for up to 30 hours as needed
 •Store prepared solution for up to 24 hours at 36 to 46 degrees Fahrenheit
 •Give with 325 mg of aspirin
 |  | 
        |  | 
        
        | Term 
 
        | Dosages for Argatroban (Acova) •Thrombin inhibitor
 |  | Definition 
 
        | •Begin infusion of 25 mcg/kg/min and administer bolus dose of 350 mcg/kg (over 3 to 5 minutes) •ACT should be checked 5 to 10 minutes after bolus
 •Proceed with procedure if ACT is > 300 seconds
 •ACT < 300 seconds: give an additional 150 mcg/kg bolus and increase infusion rate to 30 mcg/kg/min (recheck ACT in 5 to 10 minutes)
 •ACT > 450 seconds: decrease infusion rate to 15 mcg/kg/min (recheck ACT in 5 to 10 minutes)
 •Once at therapeutic ACT (300 to 450 seconds), infusion should be continued at this dose for the duration of the procedure
 •Reduce dosage to 0.5 mcg/kg/min in hepatic impairment
 •Impending abrupt closure, thrombus formation during PCI, or inability to achieve ACT > 300 seconds: an additional bolus of 150 mcg/kg, followed by an increase in infusion rate to 40 mcg/kg/min may be administered
 |  | 
        |  | 
        
        | Term 
 
        | Dosages for Aspirin •Analgesic
 •Antiplatelet
 |  | Definition 
 
        | •Analgesic/antipyretic: 325 - 650 mg PO q 4 hours as needed •Acute MI: 325 mg (or 4 x 81 mg chewable tablets to facilitate sublingual absorption and to expedite antiplatelet activity)
 •Thromboembolic disorders: 325 - 650 mg PO QD or BID
 •MI prophylaxis: 81 - 325 mg PO QD
 |  | 
        |  | 
        
        | Term 
 
        | Dosages for Clopidogrel (Plavix) •Antiplatelet
 •Anticoagulant
 |  | Definition 
 
        | •75 mg PO QD is recommended •For ACS with or without PCI, load with 300 mg and then continue with 75 mg daily
 |  | 
        |  | 
        
        | Term 
 
        | Dosages for Enalapril (Vasotec) •Antihypertensive
 |  | Definition 
 
        | •Hypertension •PO: 5 mg/day; may increase to 10 to 40 mg/day in 1-2 divided doses
 •IV: 1.25 mg slow IV push over 5 minutes every 6 hours; may give up to 5 mg every 6 hours in hypertensive emergencies
 •CHF: 2.5 mg PO QD or BID; may increase up to 5 to 20 mg/day in 1 to 2 divided doses (max of 40 mg/day
 |  | 
        |  |